This topic contains a solution. Click here to go to the answer

Author Question: Does the A-B design demonstrate a functional relationship? Why or why not? What will be an ideal ... (Read 17 times)

armygirl

  • Hero Member
  • *****
  • Posts: 556
Does the A-B design demonstrate a functional relationship? Why or why not?
 
  What will be an ideal response?

Question 2

Presenting the discriminative stimulus and cues for a behavior make the behavior ____________ likely to occur, and removing the discriminative stimulus and cues for the behavior make the behavior ____________ likely to occur.
 
  a. more; less
 b. less; more
 c. more; more
  d. less; less



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raenoj

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

No. You determine that a functional relationship exists when the target behavior changes if and only if the procedure is implemented and the process is repeated one or more times. There is no replication in an AB design.

Answer to Question 2

a





 

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Green tea is able to stop the scent of garlic or onion from causing bad breath.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

For a complete list of videos, visit our video library